The investigations of human serum pseudocholinestrase (acylcholine acylhydrolase) (Inter- (Harris, I964) .
Until now 7 cases (in 6 families) of complete pseudocholinesterase deficiency, compatible with the homozygous genotype ElsEls,have been described (Liddell, Lehmann, and Silk, I962; Doenicke, Girtner, Kreutzberg, Remes, Spiess, and Steinbereithner, I963; Hodgkin, Giblett, Levine, Bauer, and Motulsky, I965; Goedde, Fuss, Ritter, and Baitsch, i965a; Dietz, Lubrano, and Rubinstein, I965). During a survey on the frequency of atypical pseudocholinesterase in various population groups in Israel, a new case of complete absence of the enzyme was detected by us. Family examinations demonstrated a similar absence of enzyme activity in the serum of two children of the propositus (Fig.) . The present report describes the detailed findings in the affected family.
Material and Methods
The survey has been conducted on a random sample of blood bank donors and hospital patients not suffering from liver, kidney, or neoplastic diseases. All the sera were examined by the screening paper-spot test of Harris and Robson (I963) , modified as follows: filter paper Whatman No. 3IET was used instead of No. 17, the control tubes contained 0o05 ml. serum diluted in 2 ml. phosphate buffer instead of 4 ml. as originally described. All the samples, which in the screening test suggested the presence of atypical enzyme or showed low enzymatic activity, were examined for definitive classification by spectrophotometric procedures for pseudocholinesterase activity and the dibucaine number Received February 24, I966. (Kalow and Genest, I957) , fluoride number (Harris and Whittaker, i96i), and inhibition by R02-o683 (Liddell, Lehmann, and Davies, I963).
All the determinations were carried out in Beckman DU spectrophotometer at 240 m,t at 26°C. The enzyme activity was expressed in arbitrary units defined by Kalow and Lindsay (1955) The hypothesis of a suppressor of El gene was excluded on the grounds that no segregation of E.a gene was observed among relatives of persons with the hypothetical genotype E,uElaSs (s represents the suppressor gene and S its non-suppressor allele). This conclusion (with a chance probability of p=0-02) was based on results seen in I4 offspring in a critical type of mating. Hodgkin et al. (I965) suggested that more offspring from the critical matings were required to disprove this remote hypothesis.
The material available for such an analysis has now been enlarged. The critical matings analysed by the previous investigators were between normals (E,uE,uSS) and silent gene heterozygotes (EluElaSs).
3 children of such a mating were present in a family described previously by us (subjects III.3, 4, 5, in Szeinberg et al. (I965) and 3 children in the family described by Dietz et al. (I965) (subjects III.22, 23 , 24 in family G). All were phenotypically normal. Thus the number of phenotype U offspring in this type of mating is now 20, and the probability of this being a chance occurrence is (3/4)20=0.003.
In the family described here, additional types of mating provide material for testing the suppressor gene theory. Among the 6 examined children of this couple none with the atypical enzyme was found, the probability of chance being (3/4)6=0OI78.
The combined data from all the critical matings exclude the hypothesis that the silent gene is independent of E1 locus and suppresses the action of E1a gene with the probability of (3/4)20 x(ii/i6)8 communication of Harris (Hodgkin et Serum with complete absence of pseudocholinesterase activity failed to inhibit normal pseudocholinesterase activity.
Heterozygotes for the 'usual' and 'silent' genes in the present family and anothe-r one previously described by the authors had a mean of 530% of normal enzyme activity (range 40-7I %).
